411 related articles for article (PubMed ID: 30720869)
1.
Lin Y; Ma C; Bezabeh T; Wang Z; Liang J; Huang Y; Zhao J; Liu X; Ye W; Tang W; Ouyang T; Wu R
Int J Cancer; 2019 Sep; 145(6):1679-1689. PubMed ID: 30720869
[TBL] [Abstract][Full Text] [Related]
2. NMR-based fecal metabolomics fingerprinting as predictors of earlier diagnosis in patients with colorectal cancer.
Lin Y; Ma C; Liu C; Wang Z; Yang J; Liu X; Shen Z; Wu R
Oncotarget; 2016 May; 7(20):29454-64. PubMed ID: 27107423
[TBL] [Abstract][Full Text] [Related]
3. [Proton nuclear magnetic resonance spectroscopy recognition of metabolic patterns in fecal extracts for early diagnosis of colorectal cancer].
Lin Y; Wang ZN; Ma CC; Liu CK; Yang JR; Shen ZW; Wu RH
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Sep; 50(9):788-793. PubMed ID: 27655598
[No Abstract] [Full Text] [Related]
4.
Ye W; Lin Y; Bezabeh T; Ma C; Liang J; Zhao J; Ouyang T; Tang W; Wu R
NMR Biomed; 2021 Jun; 34(6):e4505. PubMed ID: 33783927
[TBL] [Abstract][Full Text] [Related]
5. Nuclear magnetic resonance-based metabolomics and metabolic pathway networks from patient-matched esophageal carcinoma, adjacent noncancerous tissues and urine.
Liang JH; Lin Y; Ouyang T; Tang W; Huang Y; Ye W; Zhao JY; Wang ZN; Ma CC
World J Gastroenterol; 2019 Jul; 25(25):3218-3230. PubMed ID: 31333313
[TBL] [Abstract][Full Text] [Related]
6. Fecal Fatty Acid Profiling as a Potential New Screening Biomarker in Patients with Colorectal Cancer.
Song EM; Byeon JS; Lee SM; Yoo HJ; Kim SJ; Lee SH; Chang K; Hwang SW; Yang DH; Jeong JY
Dig Dis Sci; 2018 May; 63(5):1229-1236. PubMed ID: 29516324
[TBL] [Abstract][Full Text] [Related]
7. (1)H NMR Spectroscopy of Fecal Extracts Enables Detection of Advanced Colorectal Neoplasia.
Amiot A; Dona AC; Wijeyesekera A; Tournigand C; Baumgaertner I; Lebaleur Y; Sobhani I; Holmes E
J Proteome Res; 2015 Sep; 14(9):3871-81. PubMed ID: 26211820
[TBL] [Abstract][Full Text] [Related]
8. Fecal metabolomic profiles: A comparative study of patients with colorectal cancer
Nannini G; Meoni G; Tenori L; Ringressi MN; Taddei A; Niccolai E; Baldi S; Russo E; Luchinat C; Amedei A
World J Gastroenterol; 2021 Oct; 27(38):6430-6441. PubMed ID: 34720532
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool.
Brown DG; Rao S; Weir TL; O'Malia J; Bazan M; Brown RJ; Ryan EP
Cancer Metab; 2016; 4():11. PubMed ID: 27275383
[TBL] [Abstract][Full Text] [Related]
10. A quantitative multimodal metabolomic assay for colorectal cancer.
Farshidfar F; Kopciuk KA; Hilsden R; McGregor SE; Mazurak VC; Buie WD; MacLean A; Vogel HJ; Bathe OF
BMC Cancer; 2018 Jan; 18(1):26. PubMed ID: 29301511
[TBL] [Abstract][Full Text] [Related]
11. Non-invasive fecal metabonomic detection of colorectal cancer.
Phua LC; Chue XP; Koh PK; Cheah PY; Ho HK; Chan EC
Cancer Biol Ther; 2014 Apr; 15(4):389-97. PubMed ID: 24424155
[TBL] [Abstract][Full Text] [Related]
12. 1H HR-MAS NMR spectroscopy of tumor-induced local metabolic "field-effects" enables colorectal cancer staging and prognostication.
Jiménez B; Mirnezami R; Kinross J; Cloarec O; Keun HC; Holmes E; Goldin RD; Ziprin P; Darzi A; Nicholson JK
J Proteome Res; 2013 Feb; 12(2):959-68. PubMed ID: 23240862
[TBL] [Abstract][Full Text] [Related]
13. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer.
Yang Y; Misra BB; Liang L; Bi D; Weng W; Wu W; Cai S; Qin H; Goel A; Li X; Ma Y
Theranostics; 2019; 9(14):4101-4114. PubMed ID: 31281534
[No Abstract] [Full Text] [Related]
14. Short-chain fatty acids reprogram metabolic profiles with the induction of reactive oxygen species production in human colorectal adenocarcinoma cells.
Huang C; Deng W; Xu HZ; Zhou C; Zhang F; Chen J; Bao Q; Zhou X; Liu M; Li J; Liu C
Comput Struct Biotechnol J; 2023; 21():1606-1620. PubMed ID: 36874158
[TBL] [Abstract][Full Text] [Related]
15. Metabolite profiling of fecal water extracts from human colorectal cancer.
Monleón D; Morales JM; Barrasa A; López JA; Vázquez C; Celda B
NMR Biomed; 2009 Apr; 22(3):342-8. PubMed ID: 19006102
[TBL] [Abstract][Full Text] [Related]
16. Identification of differential metabolic characteristics between tumor and normal tissue from colorectal cancer patients by gas chromatography-mass spectrometry.
Ning W; Li H; Meng F; Cheng J; Song X; Zhang G; Wang W; Wu S; Fang J; Ma K; Yang J; Pei D; Dong F
Biomed Chromatogr; 2017 Nov; 31(11):. PubMed ID: 28475217
[TBL] [Abstract][Full Text] [Related]
17. Fecal Metabolome in Hmga1 Transgenic Mice with Polyposis: Evidence for Potential Screen for Early Detection of Precursor Lesions in Colorectal Cancer.
Williams MD; Xian L; Huso T; Park JJ; Huso D; Cope LM; Gang DR; Siems WF; Resar L; Reeves R; Hill HH
J Proteome Res; 2016 Dec; 15(12):4176-4187. PubMed ID: 27696867
[TBL] [Abstract][Full Text] [Related]
18. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS).
Chan EC; Koh PK; Mal M; Cheah PY; Eu KW; Backshall A; Cavill R; Nicholson JK; Keun HC
J Proteome Res; 2009 Jan; 8(1):352-61. PubMed ID: 19063642
[TBL] [Abstract][Full Text] [Related]
19. Metabolomics Analysis in Serum from Patients with Colorectal Polyp and Colorectal Cancer by
Gu J; Xiao Y; Shu D; Liang X; Hu X; Xie Y; Lin D; Li H
Dis Markers; 2019; 2019():3491852. PubMed ID: 31089393
[TBL] [Abstract][Full Text] [Related]
20. From adenoma to CRC stages: the oral-gut microbiome axis as a source of potential microbial and metabolic biomarkers of malignancy.
Russo E; Gloria LD; Nannini G; Meoni G; Niccolai E; Ringressi MN; Baldi S; Fani R; Tenori L; Taddei A; Ramazzotti M; Amedei A
Neoplasia; 2023 Jun; 40():100901. PubMed ID: 37058886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]